Comparing a Tapering Strategy to the Standard Dosing Regimen of TNF Inhibitors in Patients with Rheumatoid Arthritis in Remission or with Low Disease Activity

被引：0

作者：

Plasencia-Rodriguez, Chamaida ^{[1
]}

Wolbink, G. J. ^{[2
]}

Krieckaert, Charlotte L. M. ^{[2
]}

Kneepkens, Eva L. ^{[3
]}

Turk, Samina ^{[4
]}

Gema Bonilla, Maria ^{[5
]}

Villalba, Alejandro ^{[1
]}

Peiteado, Diana ^{[1
]}

Nuno, Laura ^{[1
]}

Nurmohamed, Mike T. ^{[2
]}

Rispens, Theo ^{[6
]}

van der Kleij, Desiree ^{[7
]}

Jurado, Teresa ^{[8
]}

Martin-Mola, Emilio ^{[5
]}

Pascual-Salcedo, Dora ^{[5
]}

Balsa, Alejandro ^{[1
]}

机构：

[1] Hosp La Paz IdiPaz, Madrid, Spain

[2] Reade, Jan van Breemen Res Inst, Amsterdam, Netherlands

[3] Reade, Ctr Rehabil & Rheumatol, Amsterdam, Netherlands

[4] Reade, Amsterdam, Netherlands

[5] La Paz Univ Hosp, Madrid, Spain

[6] Sanquin Res, Amsterdam, Netherlands

[7] Sanquin Diagnost Serv, Amsterdam, Netherlands

[8] La Paz Univ Hosp Idipaz, Madrid, Spain

来源：

ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2400

引用

页码：S1046 / S1046

页数：1

共 50 条

[1] Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity
Plasencia, C.
Wolbink, G.
Krieckaert, C. L. M.
Kneepkens, E. L.
Turk, S.
Jurado, T.
Martinez-Feito, A.
Navarro-Compan, V.
Bonilla, G.
Villalba, A.
Peiteado, D.
Nuno, L.
Martin-Mola, E.
Nurmohamed, M. T.
van der Kleij, D.
Rispens, T.
Pascual-Salcedo, D.
Balsa, A.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 655 - 662
[2] Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity
Plasencia, Chamaida
Kneepkens, Eva L.
Wolbink, Gertjan
Krieckaert, Charlotte L. M.
Turk, Samina
Navarro-Compan, Victoria
L'Ami, Merel
Nurmohamed, Mike T.
van der Horst-Bruinsma, Irene
Jurado, Teresa
Diego, Cristina
Bonilla, Gema
Villalba, Alejandro
Peiteado, Diana
Nuno, Laura
van der Kleij, Desiree
Rispens, Theo
Martin-Mola, Emilio
Balsa, Alejandro
Pascual-Salcedo, Dora
[J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (09) : 1638 - 1646
[3] Rheumatoid arthritis in remission: Is tapering of TNF inhibitors possible?
Brudermanns, Britta
[J]. AKTUELLE RHEUMATOLOGIE, 2024, 49 (03) : 140 - 140
[4] Tapering Janus kinase inhibitors in rheumatoid arthritis with low disease activity or remission: reality or dream?
Singh, Jasvinder A.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (02) : 153 - 154
[5] COMPARISON OF CLINICAL OUTCOMES BETWEEN RHEUMATOID ARTHRITIS PATIENTS UNDER TNF INHIBITORS USING A TAPERING STRATEGY OR STANDARD THERAPY REGIMEN IN DAILY CLINICAL PRACTICE
Plasencia, C.
Wolbink, G.
Krieckaert, C.
Kneepkens, E.
Turk, S.
Bonilla, M.
Villalba, A.
Nurmohamed, M.
Diego, C.
Martin-Mola, E.
Pascual-Salcedo, D.
Balsa, A.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 234 - 234
[6] INFLUENCE OF THE TAPERING STRATEGY TNF INHIBITORS ON THE IMMUNOGENICITY IN A COHORT OF SPONDYLOARTHRITIS PATIENTS IN LOW DISEASE ACTIVITY
Monjo Henry, I.
Plasencia, C.
Pascual-Salcedo, D.
Paredes, B.
Pieren, A.
Tornero, C.
Moral, E.
Bonilla, G.
Nuno, L.
Peiteado, D.
Villalba, A.
Jurado, T.
Diego, C.
Diez, J.
Martin Mola, E.
Balsa, A.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 270 - 270
[7] Factors Predicting 2 Years of Remission and Low Disease Activity in Rheumatoid Arthritis Patients Treated with TNF-inhibitors
Conigliaro, Paola
Triggianese, Paola
Chimenti, Maria Sole
Tonelli, Marco
Sunzini, Flavia
Kroegler, Barbara
Perricone, Roberto
[J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2017, 19 (08): : 467 - 472
[8] RANDOMIZED TRIAL OF STOPPING TNF-INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS WITH STABLE REMISSION OR LOW DISEASE ACTIVITY IN THE NETHERLANDS
Moghadam, M. Ghiti
Vonkeman, H. E.
Ten Klooster, P. M.
van Riel, P. L.
de Laar, M. A. van
Jansen, T. L.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 709 - 709
[9] A predictive model for remission and low disease activity in patients with established rheumatoid arthritis receiving TNF blockers
Cristina Pomirleanu
Codrina Ancuta
Smaranda Miu
Rodica Chirieac
[J]. Clinical Rheumatology, 2013, 32 : 665 - 670
[10] A predictive model for remission and low disease activity in patients with established rheumatoid arthritis receiving TNF blockers
Pomirleanu, Cristina
Ancuta, Codrina
Miu, Smaranda
Chirieac, Rodica
[J]. CLINICAL RHEUMATOLOGY, 2013, 32 (05) : 665 - 670

← 1 2 3 4 5 →